 Mara Epstein
Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 12 | 2016 | 266 | 2.780 |
Why?
| | Diet | 4 | 2015 | 460 | 1.060 |
Why?
| | Hodgkin Disease | 1 | 2015 | 46 | 0.650 |
Why?
| | HIV Seronegativity | 1 | 2013 | 18 | 0.590 |
Why?
| | Prostate-Specific Antigen | 1 | 2012 | 43 | 0.530 |
Why?
| | Cause of Death | 1 | 2012 | 115 | 0.520 |
Why?
| | Risk Reduction Behavior | 1 | 2012 | 99 | 0.510 |
Why?
| | Fatty Acids | 1 | 2012 | 134 | 0.510 |
Why?
| | Vitamin D | 1 | 2012 | 110 | 0.490 |
Why?
| | Dietary Fats | 1 | 2012 | 205 | 0.490 |
Why?
| | Zinc | 1 | 2011 | 62 | 0.470 |
Why?
| | Cytokines | 1 | 2013 | 719 | 0.450 |
Why?
| | Case-Control Studies | 7 | 2016 | 660 | 0.440 |
Why?
| | Tooth Loss | 2 | 2008 | 5 | 0.410 |
Why?
| | Middle Aged | 13 | 2016 | 9874 | 0.410 |
Why?
| | Sweden | 3 | 2012 | 20 | 0.400 |
Why?
| | HIV Infections | 1 | 2013 | 655 | 0.390 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2014 | 323 | 0.390 |
Why?
| | Prospective Studies | 8 | 2014 | 1668 | 0.390 |
Why?
| | Male | 16 | 2016 | 17242 | 0.380 |
Why?
| | Endoribonucleases | 2 | 2013 | 44 | 0.370 |
Why?
| | Fruit | 2 | 2015 | 83 | 0.370 |
Why?
| | Cohort Studies | 5 | 2016 | 1417 | 0.360 |
Why?
| | Aged | 12 | 2016 | 7641 | 0.340 |
Why?
| | Risk Factors | 6 | 2015 | 3030 | 0.330 |
Why?
| | Adult | 11 | 2015 | 9698 | 0.310 |
Why?
| | Humans | 17 | 2016 | 34160 | 0.280 |
Why?
| | Neoplasms | 2 | 2008 | 599 | 0.260 |
Why?
| | Proportional Hazards Models | 5 | 2014 | 468 | 0.260 |
Why?
| | Survival Analysis | 2 | 2012 | 381 | 0.240 |
Why?
| | C-Reactive Protein | 3 | 2014 | 164 | 0.230 |
Why?
| | Aged, 80 and over | 6 | 2016 | 2864 | 0.220 |
Why?
| | Mutation, Missense | 1 | 2010 | 120 | 0.220 |
Why?
| | Registries | 2 | 2012 | 461 | 0.220 |
Why?
| | United States | 5 | 2014 | 4021 | 0.210 |
Why?
| | Human papillomavirus 16 | 1 | 2008 | 18 | 0.210 |
Why?
| | Health Personnel | 2 | 2013 | 149 | 0.210 |
Why?
| | Periodontitis | 1 | 2008 | 8 | 0.200 |
Why?
| | Head and Neck Neoplasms | 1 | 2008 | 47 | 0.200 |
Why?
| | Periodontal Diseases | 1 | 2008 | 12 | 0.200 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 97 | 0.190 |
Why?
| | Young Adult | 2 | 2015 | 2167 | 0.190 |
Why?
| | Mortality | 2 | 2012 | 82 | 0.190 |
Why?
| | BRCA2 Protein | 1 | 2016 | 4 | 0.170 |
Why?
| | Neoplasm Staging | 2 | 2011 | 261 | 0.170 |
Why?
| | Meat | 1 | 2015 | 25 | 0.170 |
Why?
| | Connecticut | 1 | 2015 | 75 | 0.160 |
Why?
| | Vegetables | 1 | 2015 | 70 | 0.160 |
Why?
| | Vasectomy | 1 | 2014 | 1 | 0.160 |
Why?
| | Time Factors | 3 | 2012 | 2605 | 0.160 |
Why?
| | Herpesvirus 4, Human | 1 | 2015 | 130 | 0.150 |
Why?
| | Life Style | 1 | 2015 | 263 | 0.150 |
Why?
| | Odds Ratio | 1 | 2015 | 620 | 0.140 |
Why?
| | Homosexuality, Male | 1 | 2013 | 30 | 0.140 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 570 | 0.140 |
Why?
| | Feeding Behavior | 1 | 2015 | 248 | 0.140 |
Why?
| | Genetic Association Studies | 1 | 2013 | 73 | 0.140 |
Why?
| | Vitamin D-Binding Protein | 1 | 2012 | 2 | 0.140 |
Why?
| | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 2 | 0.140 |
Why?
| | Retinoid X Receptor alpha | 1 | 2012 | 3 | 0.140 |
Why?
| | Steroid Hydroxylases | 1 | 2012 | 8 | 0.140 |
Why?
| | Antioxidants | 1 | 2013 | 149 | 0.140 |
Why?
| | SEER Program | 1 | 2012 | 45 | 0.130 |
Why?
| | Receptors, Calcitriol | 1 | 2012 | 26 | 0.130 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2012 | 27 | 0.130 |
Why?
| | Health Behavior | 1 | 2015 | 365 | 0.130 |
Why?
| | Seasons | 1 | 2012 | 95 | 0.130 |
Why?
| | Body Mass Index | 1 | 2015 | 718 | 0.130 |
Why?
| | Population Surveillance | 1 | 2012 | 180 | 0.120 |
Why?
| | Massachusetts | 1 | 2015 | 1482 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 479 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2011 | 300 | 0.110 |
Why?
| | Genotype | 3 | 2013 | 480 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 456 | 0.110 |
Why?
| | Databases, Factual | 1 | 2011 | 400 | 0.100 |
Why?
| | Follow-Up Studies | 3 | 2014 | 1543 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2012 | 1254 | 0.090 |
Why?
| | Incidence | 3 | 2014 | 815 | 0.090 |
Why?
| | Adolescent | 1 | 2015 | 4025 | 0.090 |
Why?
| | Disease Progression | 2 | 2016 | 479 | 0.090 |
Why?
| | Interleukin-6 | 2 | 2013 | 231 | 0.090 |
Why?
| | Risk Assessment | 2 | 2014 | 1081 | 0.060 |
Why?
| | Female | 2 | 2015 | 18881 | 0.060 |
Why?
| | Genetic Variation | 2 | 2014 | 255 | 0.060 |
Why?
| | Finland | 1 | 2010 | 18 | 0.060 |
Why?
| | Tissue Array Analysis | 1 | 2016 | 16 | 0.040 |
Why?
| | Logistic Models | 1 | 2008 | 885 | 0.040 |
Why?
| | Cytoplasm | 1 | 2016 | 230 | 0.040 |
Why?
| | Cell Membrane | 1 | 2016 | 418 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2016 | 774 | 0.040 |
Why?
| | Risk | 1 | 2014 | 346 | 0.040 |
Why?
| | Androgen Antagonists | 1 | 2013 | 9 | 0.040 |
Why?
| | Prostatectomy | 1 | 2013 | 33 | 0.030 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2013 | 20 | 0.030 |
Why?
| | Prognosis | 1 | 2016 | 937 | 0.030 |
Why?
| | Prostate | 1 | 2013 | 46 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2016 | 494 | 0.030 |
Why?
| | Smoking | 1 | 2008 | 756 | 0.030 |
Why?
| | Molecular Epidemiology | 1 | 2011 | 15 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2011 | 34 | 0.030 |
Why?
| | Inflammation | 1 | 2013 | 666 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2013 | 2667 | 0.020 |
Why?
|
|
Epstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|